Literature DB >> 11832306

Goals for benign prostatic hyperplasia therapy.

Franklin C Lowe1.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 11832306     DOI： 10.1016/s0090-4295(01)01554-0

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


× No keyword cloud information.
  3 in total

1.  Effect of Shifting from Combination Therapy to Monotherapy of α-Blockers or 5α-Reductase Inhibitors on Prostate Volume and Symptoms in Patients with Benign Prostatic Hyperplasia.

Authors:  Hyoung Woo Kim; Dae Geun Moon; Hyun Min Kim; Jong Ho Hwang; Soon Chan Kim; Sam Geuk Nam; Jun Tag Park
Journal:  Korean J Urol       Date:  2011-10-19

2.  Five-year follow-up results of a randomized controlled trial comparing bipolar plasmakinetic and monopolar transurethral resection of the prostate.

Authors:  Chang-Ying Xie; Guang-Bin Zhu; Xing-Huan Wang; Xiang-Bin Liu
Journal:  Yonsei Med J       Date:  2012-07-01       Impact factor: 2.759

3.  Effect of pulsed electromagnetic field therapy on prostate volume and vascularity in the treatment of benign prostatic hyperplasia: a pilot study in a canine model.

Authors:  Raffaella Leoci; Giulio Aiudi; Fabio Silvestre; Elaine Lissner; Giovanni Michele Lacalandra
Journal:  Prostate       Date:  2014-06-09       Impact factor: 4.104
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.